Answers are grounded in this paper and cite their sources.
The development of multidrug-resistant bacteria has revealed the need for new antimicrobial compounds. Cannabis sativa preparations have a long history of medical applications, including the treatment of infectious diseases. This review collects the information about the activity of C. sativa extracts and its main components (cannabinoids and terpenes) against pathogenic bacteria and fungus, to assess its potential using as antimicrobial agents.
No takes yet. Share an insight, caveat, or question.
Schofs et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: